Evidence map›Paper›PMID 12208883›Full record

ArticleThe Journal of experimental medicine2002

The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12.

Byung O Lee, Laura Haynes, Sheri M Eaton, Susan L Swain, Troy D Randall

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Bovine Immunity and Vitamin DMicroorganisms · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Byung O LeeTrudeau Institute, Saranac Lake, NY 12983, USA.
Laura Haynes
Sheri M Eaton
Susan L Swain
Troy D Randall
Trudeau Institute · US

Funding

THE CTL REPERTOIRE OF AGED MICEP01AG001743 · NIA · SCRIPPS RESEARCH INSTITUTE · PI KLINMAN, NORMAN R · 1985 to 2004
$8.7M
CONTROL OF B CELL TERMINAL DIFFERENTIATION--ROLE OF CD40R01AI043589 · NIAID · TRUDEAU INSTITUTE, INC. · PI RANDALL, TROY D · 1999 to 2003
$989k
RECOMBINANT POLYTYPIC CHLAMYDIA VACCINER01AI026807 · NIAID · UNIVERSITY OF CALIFORNIA IRVINE · PI DE LA MAZA, LUIS M · 1989 to 1991
–
NIAID NIH HHS AI26807NIAID NIH HHS AI43589NIAID NIH HHS R01 AI043589NIA NIH HHS AG01743NIA NIH HHS P01 AG001743
6 · The paper itself

Abstract

CD40 ligand (CD154) expression on activated T cells can be separated into an early TCR-dependent phase, which occurs between 0 and 24 h after activation, and a later extended phase, which occurs after 24 h and is reciprocally regulated by the cytokines IL-4 and IL-12. IL-4 represses, whereas IL-12 sustains CD154 expression. Consistent with this, Th1, but not Th2, cells express CD154 for extended periods. Differences in the duration of CD154 expression have important biological consequences because sustained, but not transient, expression of CD154 on activated T cells can prevent B cell terminal differentiation. Thus, the differential ability of Th cells to sustain CD154 expression is an important part of their helper function and should influence the activities of other CD40-expressing cell types.

Indexed as

AnimalsB-LymphocytesCD40 AntigensCD40 LigandCell DifferentiationInterleukin-12Interleukin-4In Vitro TechniquesKineticsLigandsLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicSignal TransductionCD40 AntigensCD40 LigandInterleukin-12Interleukin-4Ligands

Identifiers

PMID12208883
PMCPMC2194000
OpenAlexW2109617584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.